A strong genetic component is described in these neoplasms, and the most frequent mutations involve succinate dehydrogenase (comprehending A/B/C/D/AF2, collectively called SDHx mutations) and von Hippel-Lindau (VHL) genes. This evidence concerns the gene VHL and neoplasm.